Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
Although important strides have been made in targeted therapy for certain leukemias and subtypes of breast cancer, the standard of care for most carcinomas still involves chemotherapy, radiotherapy, surgery, or a combination of these. Two processes serve as obstacles to the successful treatment of c...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Cold Spring Harbor Laboratory
2018
|
| Online Access: | http://hdl.handle.net/1721.1/116972 https://orcid.org/0000-0002-0895-3557 |